Medifast
MED
277 hedge funds and large institutions have $2.06B invested in Medifast in 2021 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 72 increasing their positions, 115 reducing their positions, and 32 closing their positions.
56% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 32
6% more funds holding
Funds holding: 261 → 277 (+16)
4% more capital invested
Capital invested by funds: $1.98B → $2.06B (+$83M)
2.27% less ownership
Funds ownership: 85.02% → 82.75% (-2.3%)
37% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 115
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
58% less call options, than puts
Call options by funds: $8.51M | Put options by funds: $20.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$62M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$21.6M |
| 3 |
BlackRock
New York
|
+$20.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.76M |
| 5 |
Millennium Management
New York
|
+$6.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MRCM
Mill Road Capital Management
Greenwich,
Connecticut
|
-$33.9M |
| 2 |
Renaissance Technologies
New York
|
-$27.8M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$19.8M |
| 4 |
Two Sigma Investments
New York
|
-$19.3M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$15.5M |
MED Hedge Fund Activity: Q1 2021 in Review
277 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2021, worth a combined $2.06B — up 4.2% from $1.98B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new MED positions and 32 closed out — a net gain of 18 holders — while 72 added to existing stakes and 115 trimmed.
The largest buyer was Vanguard Group, adding an estimated $62M. The largest seller was Mill Road Capital Management, exiting entirely with an estimated $33.9M sold.
- 277 institutional investors held Medifast (MED) as of Q1 2021, up from 261 in Q4 2020.
- Funds reported $2.06B of Medifast stock for Q1 2021, up 4.2% quarter-over-quarter.
- 50 funds opened new Medifast positions in Q1 2021 and 32 closed out, a net change of +18 holders.
- The largest Medifast buyer in Q1 2021 was Vanguard Group, an estimated $62M added.
- The largest Medifast seller in Q1 2021 was Mill Road Capital Management, an estimated $33.9M sold.
Based on aggregated 13F filings for Q1 2021.